Forum for Science, Industry and Business
  • Sponsored by:
  • Siemens
  • Siemens
  • Siemens
Search our Site:

Topic (optional):

 

Home Reports Life Sciences Content

Disturbed regulation of insulin production: genome study casts new light on the origin of type 2 diabetes

next article
17.04.2008

Type 2 Diabetes is a chronic disease with rising prevalence rates throughout the world.

 

In Germany, about 8 million people are affected. These numbers could even be an underestimation as a relatively high number of undiagnosed diabetics remains. The newly-published meta analysis 1) on the genetics of type 2 diabetes casts new light on the origin of this disease.


...more about:
blood Diabetes type

With participation of scientists of the Helmholtz Zentrum Muenchen, the international study confirms findings that the disease is at least partly based on a misregulation of insulin producing cells.

The newly published meta analysis, in which 90 scientists from more than 40 centers were involved, evaluated data of 15 European and American studies. It was possible to identify six new genes that play a role in the development of type 2 diabetes. This brings the number of genes associated with the disease to 16.

Type 2 diabetes is characterized by perpetually raised blood sugar levels, which, untreated, can lead to damage of blood vessels, the kidneys and other important organs. Life style factors, such as overweight and lack of exercise, play an important role for disease aetiology. Nevertheless, a strong genetic component also underlies type 2 diabetes, which has been studied for some years, with the help of linkage and association studies.

The knowledge now gained allows new insights into the mechanisms responsible for the control of blood sugar levels in the blood.

The meta analysis comprises altogether studies with more than 70,000 participants. As a German contribution, data from about 2,700 participants of the KORA study were included. The involved scientists from Germany were Harald Grallert, Dr. Christa Meisinger and Dr. Thomas Illig, from the Helmholtz Zentrum Muenchen, in close collaboration with Dr. Christian Herder and Dr. Wolfgang Rathmann, from the German Diabetes Center in Duesseldorf.

The head of the KORA study (Cooperative Health Research in the Region of Augsburg) is the director of the Institute of Epidemiology in the Helmholtz Zentrum Muenchen, Prof. Dr. Dr. H.-Erich Wichmann. The coordinator of the analysis was Dr. Eleftheria Zeggini, University of Oxford, under the direction of Prof. Mark McCarthy.

Michael van den Heuvel | Source: alphagalileo
Further information:
www.helmholtz-muenchen.de/en/press/press/press-releases-2008/press-releases-2008-detail/article/781/9/index.html

Further Reports about: blood Diabetes type

next article

More articles from Life Sciences:

nachricht New beta-blocker to offer hope to heart and lung sufferers
29.08.2008 | University of Nottingham

nachricht Antidepressants Need New Nerve Cells to be Effective
29.08.2008 | UT Southwestern Medical Center

B2B Search

Product / Service
Company / Organisation

Latest News

Internet law made simple

29.08.2008 | Information Technology

Why did the squirrel cross the road?

29.08.2008 | Studies and Analyses

Revealed: The secret of plasma heating

29.08.2008 | Physics and Astronomy